Stay updated on Androgen Annihilation in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Androgen Annihilation in Prostate Cancer Clinical Trial page.

Latest updates to the Androgen Annihilation in Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check10 days agoChange DetectedAn NIH announcement appears above the study record, noting a website transition and a temporary shift from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.5%

- Check17 days agoChange DetectedClinicalTrials.gov added version 22 of the study record, listing changes to study status and outcome measures, including results. Its quality-control review had not concluded and was returned on October 15, 2026.SummaryDifference0.6%

- Check24 days agoChange DetectedThe footer’s ClinicalTrials.gov revision indicator changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check38 days agoChange DetectedReturned: 2026-09-21 is shown with a QC review in progress, and new core sections (Outcome Measures, Baseline Characteristics, Participant Flow, Study Design, Study Status) are now visible in the study history.SummaryDifference0.8%

- Check45 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0 on the study history page. This signals a new page template version.SummaryDifference0.1%

Stay in the know with updates to Androgen Annihilation in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Androgen Annihilation in Prostate Cancer Clinical Trial page.